For research use only · Not for human consumption
This material is reference information for laboratory study of research peptides. It is not medical advice and it is not instructions for human use, self-administration, or therapeutic application. Capital Peptides supplies research chemicals for in-vitro and animal-model study only. Discuss any health-related questions with a licensed medical practitioner.
1. Why people mix
When running a stack (e.g., CJC-1295 + ipamorelin), mixing both into a single syringe means one injection instead of two. For peptides taken 1–2x daily, this meaningfully reduces injection frequency and site fatigue over a 12-week cycle.
Mixing is only appropriate when the compounds are chemically compatible — some peptides interact unfavourably in solution.
2. Compatible combinations
| Combination | Notes |
|---|---|
| CJC-1295 (No-DAC) + Ipamorelin | The most common mix. Fully compatible. Widely used. |
| CJC-1295 (No-DAC) + GHRP-2 or GHRP-6 | Compatible. Same GH axis; complementary mechanism. |
| BPC-157 + TB-500 | Compatible in solution. Can be drawn together. Some pre-made blends exist. |
| Sermorelin + Ipamorelin | Compatible. Common alternative to CJC combinations. |
| Semax + Selank (intranasal) | Compatible for intranasal use in the same bottle. |
3. Combinations to avoid mixing
| Combination | Why to keep separate |
|---|---|
| CJC-1295 with DAC + anything | Long-acting (DAC) GHRH analogues are typically dosed 1–2x per week; mixing with short-acting compounds creates incompatible dosing schedules even if chemically compatible. |
| GLP-1 agonists + any GH peptide | Different injection volumes, different concentrations, weekly vs daily dosing. Keep separate to avoid dosing errors. |
| Any two peptides at highly different pH | Most research peptides are stable in the same pH range when reconstituted in BAC water — but some exotic peptides have specific pH requirements. Check individual reconstitution notes. |
| Peptides with documented instability in combination | PT-141 with peptides containing disulfide bonds can cause oxidation. When uncertain, inject separately. |
4. The correct mixing order
When drawing two peptides into one syringe, order matters to minimise cross-contamination of vials:
- Draw air equal to your first peptide dose. Inject into vial 1. Draw the correct units of peptide 1.
- Without changing the needle (you're injecting into a second vial, not a person), draw air equal to your second peptide dose. Inject into vial 2. Draw the correct units of peptide 2.
- You now have both peptides in the syringe. Do not push back into either vial — the mixture cannot go back in without contaminating the source vials.
- Check total units in the syringe against your planned combined dose.
- Inject immediately.
5. When NOT to mix
- When the two compounds require different timing (e.g., one fasted, one with food)
- When troubleshooting — if you're experiencing a side effect and need to isolate which compound is responsible, inject separately
- When the concentrations result in very different unit volumes (hard to draw accurately)
- On your first week with a new compound — establish individual tolerability before combining
- Any time you're uncertain about compatibility — separate injections are always safe